JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riker, W. F.
Right arrow Articles by Wescoe, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riker, W. F., Jr.
Right arrow Articles by Wescoe, W. C.
Journal of Pharmacology And Experimental Therapeutics, Vol. 100, Issue 4, 454-464, 1950
Copyright © 1950 by American Society for Pharmacology and Experimental Therapeutics


STUDIES ON THE INTER-RELATIONSHIP OF CERTAIN CHOLINERGIC COMPOUNDS

V. The Significance of the Actions of the 3-Hydroxy Phenyltrimethylammonium Ion on Neuromuscular Function

Walter F. Riker Jr. 1 and W. Clarke Wescoe 1

1 Department of Pharmacology, Cornell University Medical College, New York 21, N.Y.

The pharmacologic effects of 3-hydroxy phenyltrimethylammonium bromide (Nu 2561) are characterized by a high specificity for the neuromuscular junction. Accordingly, the effects of this substance on neuromuscular function were demonstrated in the cat. These actions include:

(1) the production of a characteristic acetylcholine-like response in chronically denervated muscle,

(2) the augmentation of the contractile response of innervated muscle to single maximal motor nerve stimuli,

(3) the production of repetitive and asynchronous propagated potentials in response to a single maximal motor nerve shock,

(4) a prominent anti-curare action,

(5) a transient curariform effect that is antagonized reciprocally by curare and

(6) potentiating effects on neuromuscular function that cannot be enhanced significantly by cholinesterase inactivation.

The duration of action of Nu 2561 at the junctional region is brief (approximately three minutes) but despite this, its anti-curare effect is permanent.

These findings are discussed with relation to their implications concerning the actions of related substances on neuromuscular function. In addition, an hypothesis is presented to explain the way in which Nu 2561, and probably related agents, effect de-curarization.

Finally, the data are discussed with regard to the significance of the 3-hydroxy phenyltrimethylammonium structure for musculotropic activity.

Submitted on August 10, 1950




This article has been cited by other articles:


Home page
Arch NeurolHome page
W. F. Riker Jr.
Pharmacologic Considerations in a Reevaluation of the Neuromuscular Synapse
Arch Neurol, November 1, 1960; 3(5): 488 - 499.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1950 by the American Society for Pharmacology and Experimental Therapeutics.